PVH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
PVH is not a good buy right now for an impatient investor. The broader trend remains bearish (SMA200 > SMA20 > SMA5), fundamentals in the latest quarter show a severe earnings collapse, options positioning leans defensive (put/call ratios > 1), and near-term pattern-based odds skew negative over the next week/month. Despite a modest MACD improvement and a potentially positive AI-efficiency headline, the current setup favors avoiding new longs (or trimming exposure) rather than buying immediately.
Trend/price structure: The moving-average stack is bearish (SMA200 > SMA20 > SMA5), implying the stock is still in a downtrend despite today’s small bounce to 61.83. Momentum: MACD histogram is positive and expanding (0.0633), suggesting downside momentum is easing and a short-term rebound is possible, but it has not yet reversed the higher-timeframe downtrend. RSI: RSI(6) at ~41.7 is neutral-to-weak, consistent with a market that is not oversold enough to force a durable snapback. Levels: Immediate support is S1 ~60.84 (then S2 ~59.13). Price is below the pivot ~63.62, so rallies face overhead supply; resistance sits near 66.39 then 68.10. Pattern/quant bias: Similar-pattern stats indicate ~-3.65% next week and ~-13.05% next month, reinforcing a bearish near-term bias.
Intellectia Proprietary Trading Signals
Latest quarter: 2026/Q3. Revenue increased to $2.294B (+1.74% YoY), but profitability collapsed: net income fell to ~$4.2M (-96.82% YoY) and EPS to $0.09 (-96.15% YoY). Gross margin declined to ~56.35% (-3.48% YoY). Net result: growth is modest while margins/earnings are deteriorating sharply—an unfavorable trend for a buy-right-now decision.
Recent trend: Analysts have generally leaned Neutral/market-perform with multiple small price-target reductions (Citi to $80, Wells Fargo to $85, BofA to $87), plus a notable downgrade from Telsey to Market Perform with PT cut to $82 (from $95). Guggenheim initiated at Neutral. The main bullish outlier is Needham maintaining Buy with a $100 PT, framing upside as contingent on stabilization.
Wall Street pros: Potential upside if operations stabilize; some see the stock as inexpensive versus earnings power. Wall Street cons: Transition/integration risk (bringing licensed businesses in-house), regional softness (notably EMEA concerns cited), margin volatility, and a tougher operating backdrop—leading most firms to stay on the sidelines.
